Despite being a cornerstone of cancer treatment advancement, clinical trials remain inaccessible for many patients because of structural, socioeconomic, and systemic barriers. In this ...

The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...

Progress in medicine is made possible through the contributions of many people, including patients, families, caregivers, and health care professionals who support and participate in clinical research ...

A group of 131 healthcare organizations sent a letter on Monday to U.S. House Representatives supporting the recent introduction of the Clinical Trial Modernization Act. The bill aims to make it ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

New drugs and devices are transforming the treatment of diseases that affect millions of Americans, including cancer, diabetes, sleep apnea and obesity. At the same time, gene therapies are giving ...

Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.

What Are Clinical Trials for MASH? Clinical trials for MASH are research studies that evaluate potential new treatments for a form of liver disease called metabolic dysfunction-associated ...

Felicione is an independent clinical research scientist and principal investigator. Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising ...